VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $427,000 | -40.8% | 29,382 | 0.0% | 0.13% | -16.8% |
| Q3 2016 | $721,000 | +21.8% | 29,382 | 0.0% | 0.16% | +10.3% |
| Q2 2016 | $592,000 | -23.4% | 29,382 | 0.0% | 0.15% | -32.4% |
| Q1 2016 | $773,000 | -74.1% | 29,382 | 0.0% | 0.22% | -71.4% |
| Q4 2015 | $2,987,000 | -19.2% | 29,382 | +41.9% | 0.76% | +4.7% |
| Q3 2015 | $3,695,000 | -5.9% | 20,712 | +17.2% | 0.72% | +17.0% |
| Q2 2015 | $3,927,000 | +11.8% | 17,678 | 0.0% | 0.62% | +10.0% |
| Q1 2015 | $3,511,000 | +38.8% | 17,678 | 0.0% | 0.56% | +39.3% |
| Q4 2014 | $2,530,000 | +9.1% | 17,678 | 0.0% | 0.40% | +1.5% |
| Q3 2014 | $2,319,000 | +37.8% | 17,678 | +32.5% | 0.40% | +45.1% |
| Q2 2014 | $1,683,000 | +11.8% | 13,343 | +16.9% | 0.27% | +5.4% |
| Q1 2014 | $1,505,000 | – | 11,418 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |